| Dynavax Resumes Hepatitis B Vaccine Trial After 18-Month Hold - Update - RTT News |
|
|
RTT NewsAccording to statistics, there are about 750000 end-stage renal disease, or ESRD, patients in the United States and the 5 major European markets and ...Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney ... read more |